1:00 PM ET, 6:00 PM GMT (Convert this time to your time zone)
Patient-derived xenograft (PDX) cancer models show great promise as preclinical models because they recapitulate the heterogeneity of human cancer in a manner that is easily accessible for the research community. The JAX® PDX program was developed in collaboration with renowned cancer hospitals to advance the course of preclinical drug development. In this webinar, you will...
Please use an institutional email address when registering for this webinar or contact our webinar staff to request an exception.
Subscribe to the JAX Webinar™ mailing list to receive monthly announcements about upcoming complimentary webinars (2-4 each month) on current and cutting edge topics related to using mouse models in biomedical research.
Registration is Open